Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

The Blood-brain Barrier

The Blood-brain Barrier

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Physiological Barriers

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inverse design and discovery of high entropy alloy catalysts for efficient oxygen evolution reaction.

The Journal of chemical physics·2026

Same author

Reliability of Singh's Index and Calcaneal Index in Assessing Osteoporosis Compared with Quantitative Ultrasound Bone Mineral Density.

Journal of orthopaedic case reports·2026

Same author

Immunohistochemical Expression of Vimentin in Breast Carcinoma and Its Correlation With Histopathological Prognostic Factors.

Cureus·2026

Same author

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

The oncologist·2026

Same author

Optimizing cervical cancer diagnosis with a hybrid deep neural network and progressive resizing on pap smear WSIs.

Scientific reports·2026

Same author

Nanomedicine-Based Approaches for Therapeutic Delivery Across the Blood-Brain Barrier in Neurological Disorders.

Current pharmaceutical design·2026

Search research articles

Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).

Ankit Jain¹, Sanjay K Jain¹

¹Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (M.P.), India.

Critical Reviews in Therapeutic Drug Carrier Systems

|May 9, 2015

Summary

Overcoming the blood-brain barrier (BBB) is crucial for brain drug delivery. This review explores advanced nanocarrier strategies and targeting tactics to enhance therapeutic transport across the BBB.

More Related Videos

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Experiment Videos

Last Updated: Apr 12, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Area of Science:

Neuroscience
Pharmacology
Biotechnology

Background:

The blood-brain barrier (BBB) presents a significant obstacle for delivering therapeutics to the brain.
Understanding endogenous transport mechanisms (carrier-mediated, active efflux, receptor-mediated) is key for brain targeting.

Purpose of the Study:

To review recent advancements in safe and efficient brain drug delivery.
To highlight novel strategies for targeting the BBB.

Main Methods:

Exploration of nanocarriers (liposomes, nanoparticles) with surface modifications and ligand appending.
Investigation of various targeting tactics like antibody-directed enzyme prodrug therapy and chimeric peptides.

Main Results:

Development of nanocarriers with appended ligands (e.g., peptides, transferrin) for enhanced BBB penetration.
Successful application of advanced BBB targeting strategies.

Conclusions:

Nanocarrier-based approaches and innovative targeting tactics show promise for overcoming BBB challenges.
This review provides valuable insights for researchers in brain drug delivery.